Krakowski Program Wtórnej Prewencji Choroby Niedokrwiennej Serca. Porównanie realizacji wtórnej prewencji choroby niedokrwiennej serca w okresie hospitalizacji w latach 1996/97 i 1998/99.

Translated title of the contribution: Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99

Andrzej Pajak, Kalina Kawecka-Jaszcz, Piotr Jankowski, Grzegorz Bilo, Jacek S. Dubiel, Janusz Maciejewicz, Wiesław Piotrowski, Wanda Smielak-Korombel, Wiesława Tracz

Research output: Contribution to journalArticlepeer-review

Abstract

INTRODUCTION: Hospitalization for ischaemic heart disease is a convenient moment to initiate pharmacological and non-pharmacological treatment as well as education of patients. The aim of the study was to assess the quality of medical care in the field of secondary prevention in patients hospitalized for ischaemic heart disease in cardiac departments of university and general hospitals in 1998/99 as compared with 1996/97. MATERIAL: Consecutive patients were recruited on the basis of hospital records review of six cardiac departments (three in the university and three in general hospitals) in 1998/99. Inclusion criteria were: age <or = 70 years, inhabitance in the city of Cracow and its province and hospitalization due to: myocardial infarction, unstable angina, coronary angioplasty or coronary-aortic bypass grafting. METHODS: Hospital records of the included patients were reviewed. Data on previous history of ischaemic heart disease, on risk factors (including smoking, hypertension, diabetes, dyslipidemia, obesity) and drugs prescribed at discharge were obtained based on a predefined questionnaire. RESULTS: The frequency of blood pressure measurement in the first 24 hours of hospitalization was 88.8% in 1996/97 vs 95.7% in 1998/99 (p <0.001). In the first 24 hours after admission total cholesterol concentration was measured in 32.8% and 45.0% of patients (p <0.001), HDL cholesterol in 30.2% and 41.9% (p <0.001) and triglycerides in 32.3% and 44.5% (p <0.001), respectively. Both height and body mass were documented in 54.3% and 61.7% (p <0.05) of the reviewed charts. Antiplatelet drugs were prescribed at discharge in 86.7% and 90.7% of patients (p <0.05), beta-blockers in 66.4% and 61.9%, ACE inhibitors in 50.2% and 52.8%, while lipid lowering drugs in 27.1% and 41.6% (p <0.001), respectively. CONCLUSION: In 1998/99 compared with 1996/97 the quality of care in the field of secondary prevention of ischaemic heart disease was improved in cardiac departments of university and general hospitals in Cracow.

Translated title of the contributionCracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99
Original languagePolish
Pages (from-to)136-141
Number of pages6
JournalPrzeglad Lekarski
Volume60
Issue number3
Publication statusPublished - 2003

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99'. Together they form a unique fingerprint.

Cite this